Overview of methodology for lung cancer evidence review and guideline development

Douglas C McCrory1, Gene L Colice, Sandra Zelman Lewis

  • 1Department of Medicine, Duke University Medical Center, Durham, NC 27705, USA. douglas.mccrory@duke.edu

Chest
|January 16, 2003
PubMed

Insights

The American College of Chest Physicians developed 20 clinical practice guidelines for lung cancer prevention, diagnosis, and treatment. This article details the evidence-based approach used to create these comprehensive lung cancer management recommendations.

Area of Science:

  • Pulmonology
  • Oncology
  • Evidence-Based Medicine

Background:

  • Lung cancer remains a leading cause of cancer mortality worldwide.
  • Clinical practice guidelines are essential for standardizing and improving patient care.
  • The American College of Chest Physicians (ACCP) recognized the need for updated lung cancer guidelines.

Purpose of the Study:

  • To develop comprehensive clinical practice guidelines for lung cancer.
  • To cover key aspects of lung cancer management: prevention, diagnosis, and treatment.
  • To provide evidence-based recommendations for clinicians.

Main Methods:

  • Convening a multidisciplinary expert panel.
  • Systematic identification, evaluation, and synthesis of relevant scientific evidence.
  • Assessing the strength of evidence for each guideline.
  • Grading the recommendations based on the evidence.

Main Results:

  • Development of 20 distinct clinical practice guidelines.
  • Guidelines address a wide range of lung cancer management decisions.
  • The process involved rigorous evidence appraisal and synthesis.

Conclusions:

  • The ACCP has produced a robust set of guidelines for lung cancer care.
  • These guidelines aim to improve patient outcomes through evidence-based practice.
  • The methodology ensures transparency and reliability in recommendations.